Cargando…
中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（2020年版）
Non-small cell lung cancer (NSCLC) is the most common pathological type of lung cancer. The systemic antitumor therapy of advanced NSCLC has undergone renovations of chemotherapy, targeted therapy and immunotherapy, which results in greatly improved survival for patients with advanced NSCLC. Immune...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105610/ https://www.ncbi.nlm.nih.gov/pubmed/33896153 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.13 |